MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. The company was founded in 2025 and is based in Lausanne, Switzerland. Show more
Chemin de Roseneck 5, Lausanne, 1006, Switzerland
Market Cap
6.407M
52 Wk Range
$0.33 - $4.88
Previous Close
$0.51
Open
$0.48
Volume
3,099
Day Range
$0.48 - $0.51
Enterprise Value
34.19M
Cash
12.5M
Avg Qtr Burn
N/A
Insider Ownership
53.38%
Institutional Own.
26.02%
Qtr Updated
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
RLF-TD011 (APR-TD011) Details Epidermolysis bullosa | Phase 1 Update |